An End to Gene Patents?

Email a Friend
ACLU First Amendment Working Group attorney, Chris Hansen, talks about this week’s New York federal court ruling that declared patents on genes associated with hereditary breast and ovarian cancer invalid. And Nathan Tinker, executive director of the New York Biotechnology Association, explores the ruling's potential impact on the biotech industry.